Chris Masterson started with Ipsen in March 2015, based in the US, and following a period in the UK as head of the global Quality function moved back to the US to help build a US Quality hub for Ipsen. Chris’ experience spans over 20 years in the biopharma industry in increasingly senior global Quality positions for companies such as Shire, Abbott, Biogen, AstraZeneca and, most recently, at Cubist Pharmaceuticals (now Merck) in the US, where he was the global VP of Quality.  Chris’ experience spans all good pharmaceutical practices, including GMP, GDP, GCP, GVP and GLP.  Chris’ focus over the last decade has been in transforming, growing and improving Quality organizations to become not only globally compliant, but also delivering excellence and cross-functional working to optimize company performance and efficiencies. Building a Quality culture and embedded Quality mindset is his primary focus. Chris has been a member of the Parenteral Drug Society for the last 20 years. He is a respected leader and strategist in global Pharmaceutical Quality, and has led numerous successful health authority inspections with agencies including FDA, European agencies such as MPA (Sweden), MHRA (UK) and AIFA (Italy) as well as Irish, Brazilian, Japanese, Chinese and Middle East authorities. Chris is a microbiologist with a degree from the University of Massachusetts at Amherst in the USA. Chris Masterson started with Ipsen in March 2015, based in the US, and following a period in the UK as head of the global Quality function moved back to the US to help build a US Quality hub for Ipsen. Chris’ experience spans over 20 years in the biopharma industry in increasingly senior global Quality positions for companies such as Shire, Abbott, Biogen, AstraZeneca and, most recently, at Cubist Pharmaceuticals (now Merck) in the US, where he was the global VP of Quality.  Chris’ experience spans all good pharmaceutical practices, including GMP, GDP, GCP, GVP and GLP.  Chris’ focus over the last decade has been in transforming, growing and improving Quality organizations to become not only globally compliant, but also delivering excellence and cross-functional working to optimize company performance and efficiencies. Building a Quality culture and embedded Quality mindset is his primary focus. Chris has been a member of the Parenteral Drug Society for the last 20 years. He is a respected leader and strategist in global Pharmaceutical Quality, and has led numerous successful health authority inspections with agencies including FDA, European agencies such as MPA (Sweden), MHRA (UK) and AIFA (Italy) as well as Irish, Brazilian, Japanese, Chinese and Middle East authorities. Chris is a microbiologist with a degree from the University of Massachusetts at Amherst in the USA.

Regulatory Affairs